Skip to main content
. Author manuscript; available in PMC: 2024 Sep 1.
Published in final edited form as: Cancer. 2023 Jun 1;129(17):2741–2753. doi: 10.1002/cncr.34818

Figure 1. CONSORT diagram for the epigenetic aging sub-study within the Thinking and Living with Cancer (TLC) Study.

Figure 1.

CONSORT diagram showing the sample of (a) older breast cancer survivors and (b) matched controls without cancer. This epigenetic aging study includes a subset of women who provided two blood samples between 24- and 60-months post-enrollment (which was pre-systemic therapy for survivors). Non-cancer controls were frequency-matched to survivors based on age (within 5 years), racial group, education, enrollment site, and time between blood samples.